ID Week 25

ID Week 2025

IDWeek, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists, will be held from October 19-22 in Atlanta, Georgia. The meeting features education sessions, abstracts, networking opportunities, and more. This premier event offers updates on recent advances in clinical care and research in infectious diseases and health care epidemiology to support clinicians, investigators, and pharmacists.

ID Week 2025

Day 1

Assessing Multidrug ART Combinations in Older Individuals Living With HIV

Injectable Regimen Preferred by Patients With HIV to Support Treatment Adherence

EHR Algorithm Outperforms Screening Alone in Identifying Out-of-Care Patients With HIV

Men, Hispanic Patients With HIV Have Highest Rates of In-Hospital Deaths

Day 2

Black Women Report Positive Experience With Long-Acting Injectable PrEP

Lenacapavir Shows No Effect on Gender-Affirming Hormone Levels in Diverse PrEP...

Gaps in Communication Lead to Missed Care, Late-Stage HIV Diagnoses

How Zoster Vaccination Status in People With HIV Affects Risk of...

Day 3

Treatment Regimen, Mental Health Influence Persistence After ART Restart

Lenacapavir Triplet Regimen is Safe, Tolerable in Patients With HIV-1

DYAD Study Extension Confirms Long-Term Efficacy of DTG/3TC vs B/F/TAF

Success Loading: Digital App Improves Persistence With Injectable PrEP

Day 4

Falling Short: New Research Finds Missed Opportunities in the PrEP Care...

Study Shows Strong Growth in Long-Acting Cabotegravir Adoption, Especially Among PrEP-Naïve...

Real-World Data Show Gaps in STI Testing Adherence Among PrEP Users

Study Finds Lenacapavir Could Be Produced for $25 Annually, Expanding Access...

Quick Links